D
Doser provides automated 3D compounding technology, DoseRx1, enabling pharmacists to produce personalized medication locally and on demand. This platform supports tailored drug formulations, including adjustments to shape, taste, and release profiles, addressing pharmacogenomic needs. The technology standardizes manual compounding processes to deliver improved quality tablets for optimized patient treatment solutions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Doser provides 3D compounding technology that enables pharmacists to produce personalized medication locally and on demand. Their plug-and-play device automates and standardizes manual compounding processes, improving tablet quality for tailored patient treatments. This technology supports exploration of new drug formulations, including combination therapy and modified release products.